ARDC Research Link Australia Research Link Australia   BETA Research
Link
Australia
  • ARDC Newsletter Subscribe
  • Contact Us
  • Home
  • About
  • Feedback
  • Explore Collaborations
  • Researcher
  • Funded Activity
  • Organisation
  • Researcher
  • Funded Activity
  • Organisation
  • Researcher
  • Funded Activity
  • Organisation

Need help searching? View our Search Guide.

Advanced Search

Current Selection
Field of Research : Immunology
Australian State/Territory : NSW
Research Topic : Prevention programs
Status : Closed
Clear All
Filter by Field of Research
Immunology (10)
Cellular Immunology (4)
Biological Mathematics (3)
Veterinary Sciences (3)
Immunogenetics (2)
Virology (2)
Animal Protection (Pests And Pathogens) (1)
Biotechnology Not Elsewhere Classified (1)
Environmental Science and Management (1)
Epidemiology (1)
Immunology Not Elsewhere Classified (1)
Infectious Agents (1)
Infectious Diseases (1)
Medical Mycology (1)
Microbiology (1)
Protein Targeting And Signal Transduction (1)
Transplantation Immunology (1)
Wildlife And Habitat Management (1)
Filter by Socio-Economic Objective
Prevention—biologicals (e.g. vaccines) (10)
Infectious diseases (6)
Immune system and allergy (4)
Minor livestock (e.g. horses, goats, deer) (2)
Biological sciences (1)
Diagnostics (1)
Pigs (1)
Recreation (1)
Filter by Funding Provider
Australian Research Council (10)
Filter by Status
Closed (10)
Filter by Scheme
Linkage Projects (6)
Discovery Projects (2)
ARC Future Fellowships (1)
Linkage Infrastructure, Equipment and Facilities (1)
Filter by Country
Australia (10)
Filter by Australian State/Territory
NSW (10)
VIC (2)
QLD (1)
  • Researchers (9)
  • Funded Activities (10)
  • Organisations (5)
  • Funded Activity

    Linkage Projects - Grant ID: LP0667858

    Funder
    Australian Research Council
    Funding Amount
    $331,000.00
    Summary
    Reducing antibiotic usage in pig herds: controlling Lawsonia intracellularis by vaccination, housing and hygiene. Pigs are major consumers of antibiotics in Australia. Many of these antibiotics are fed to pigs to prevent proliferative enteritis (PE). There are increasing public concerns regarding the development and spread of antibiotic-resistant bacteria and the potential impact on human health. The adoption of an effective commercial vaccine to prevent PE will reduce the volume of antibiotics .... Reducing antibiotic usage in pig herds: controlling Lawsonia intracellularis by vaccination, housing and hygiene. Pigs are major consumers of antibiotics in Australia. Many of these antibiotics are fed to pigs to prevent proliferative enteritis (PE). There are increasing public concerns regarding the development and spread of antibiotic-resistant bacteria and the potential impact on human health. The adoption of an effective commercial vaccine to prevent PE will reduce the volume of antibiotics used in the pig industry and hence reduce the risk of antibiotic-resistant bacteria developing.
    Read more Read less
    More information
    Funded Activity

    Linkage Projects - Grant ID: LP0990147

    Funder
    Australian Research Council
    Funding Amount
    $290,000.00
    Summary
    Development of an anti-Chlamydia vaccine for the koala. The koala is one of Australia's main icons and a major drawcard for tourists. However, it suffers from debilitating disease due to the bacterium Chlamydia, which can lead to severe conjunctivitis, eventual blindness in both sexes, and the females develop untreatable cysts and can become infertile. This project will develop a Chlamydia vaccine to be administered to healthy and diseased koalas in zoos, sanctuaries, koala care centres, relocat .... Development of an anti-Chlamydia vaccine for the koala. The koala is one of Australia's main icons and a major drawcard for tourists. However, it suffers from debilitating disease due to the bacterium Chlamydia, which can lead to severe conjunctivitis, eventual blindness in both sexes, and the females develop untreatable cysts and can become infertile. This project will develop a Chlamydia vaccine to be administered to healthy and diseased koalas in zoos, sanctuaries, koala care centres, relocation programs and eventually perhaps even wild populations. The vaccine findings may also be transferable to other animals and may also even assist the development of a human Chlamydia vaccine.
    Read more Read less
    More information
    Funded Activity

    Linkage Projects - Grant ID: LP0560507

    Funder
    Australian Research Council
    Funding Amount
    $240,000.00
    Summary
    Oral Delivery - A Viable Strategy for Fertility Control Vaccination of Kangaroos ? Local overabundance of kangaroos poses significant, environmental, economic, social and animal welfare problems in Australia. The only management tool available for free ranging populations is shooting. Fertility control is a highly desirable alternative but current 'hands on' methods are not cost-effective options for wild populations. Immunologically-mediated contraception has the potential to be such a manag .... Oral Delivery - A Viable Strategy for Fertility Control Vaccination of Kangaroos ? Local overabundance of kangaroos poses significant, environmental, economic, social and animal welfare problems in Australia. The only management tool available for free ranging populations is shooting. Fertility control is a highly desirable alternative but current 'hands on' methods are not cost-effective options for wild populations. Immunologically-mediated contraception has the potential to be such a management tool if the vaccine can be delivered effectively. The investigators and their colleagues have achieved contraception by vaccine injection in kangaroos. This project aims to establish proof-of-concept for arguably the only viable vaccine delivery option for free ranging macropods: Oral delivery via an edible pellet or lick.
    Read more Read less
    More information
    Funded Activity

    Discovery Projects - Grant ID: DP1095581

    Funder
    Australian Research Council
    Funding Amount
    $650,000.00
    Summary
    Understanding the dynamics of T cell responses to chronic infection. The health, social, and economic impact of chronic infections on the Australian and global populations is enormous. A major obstacle to the development of vaccines against chronic infections is that we have a poor understanding of immune responses to persistent infections. We aim to use bioinformatics and mathematical modelling to understand immune responses to persistent viruses so that we can improve the long-term immune cont .... Understanding the dynamics of T cell responses to chronic infection. The health, social, and economic impact of chronic infections on the Australian and global populations is enormous. A major obstacle to the development of vaccines against chronic infections is that we have a poor understanding of immune responses to persistent infections. We aim to use bioinformatics and mathematical modelling to understand immune responses to persistent viruses so that we can improve the long-term immune control of chronic viral infections such as the human immunodeficiency virus (HIV). This project will strengthen Australian research in the area of interdisciplinary approaches to immunology, which is becoming crucial to interpreting the rapidly increasing volume of data obtained using advanced experimental techniques.
    Read more Read less
    More information
    Funded Activity

    ARC Future Fellowships - Grant ID: FT0992111

    Funder
    Australian Research Council
    Funding Amount
    $686,400.00
    Summary
    T cell recognition and control of virus: the balance between T cell receptor diversity and degeneracy. T cells provide an important line of defence in the immune system's resistance against infectious diseases. However, changes to the T cell population during prolonged infection, and with age, can compromise the immune system's ability to fight effectively viral infections. The proposed research will greatly improve our understanding of the recognition and control of viral infections by T cells. .... T cell recognition and control of virus: the balance between T cell receptor diversity and degeneracy. T cells provide an important line of defence in the immune system's resistance against infectious diseases. However, changes to the T cell population during prolonged infection, and with age, can compromise the immune system's ability to fight effectively viral infections. The proposed research will greatly improve our understanding of the recognition and control of viral infections by T cells. The insights gained from this research will enable us to exploit key features of T cell responses to improve the outcome of viral infections in elderly individuals and to develop better vaccines for protection against a range of infectious diseases that affect the Australian population, including HIV and Hepatitis C.
    Read more Read less
    More information
    Funded Activity

    Linkage Infrastructure, Equipment And Facilities - Grant ID: LE0883068

    Funder
    Australian Research Council
    Funding Amount
    $150,000.00
    Summary
    Dako ACIS III Cellular Image Acquisition and Analysis System. The scientific advances that will be possible with the acquisition of this novel, cutting-edge instrument will enhance the research outputs of all investigators using it. The ability to visualize and analyze cells and tissues from many different animal species, to elucidate both normal and abnormal functions, will be enhanced by the use of this technology. This will lead to production of quantitative statistical data that in turn will .... Dako ACIS III Cellular Image Acquisition and Analysis System. The scientific advances that will be possible with the acquisition of this novel, cutting-edge instrument will enhance the research outputs of all investigators using it. The ability to visualize and analyze cells and tissues from many different animal species, to elucidate both normal and abnormal functions, will be enhanced by the use of this technology. This will lead to production of quantitative statistical data that in turn will inform new approaches to improve and maintain the health of humans and other animals.
    Read more Read less
    More information
    Funded Activity

    Discovery Projects - Grant ID: DP0771340

    Funder
    Australian Research Council
    Funding Amount
    $396,000.00
    Summary
    Understanding the T cell repertoire in health and disease. Immune recognition of viruses usually involves a large number of different 'killer T cells' that kill cells infected by virus. However, during prolonged infection or in the elderly the number of different killer T cells that recognise the virus is greatly reduced. This reduction in the diversity of the immune response allows the virus to avoid immune recognition, and leads to more severe infection. We aim to understand how diversity is .... Understanding the T cell repertoire in health and disease. Immune recognition of viruses usually involves a large number of different 'killer T cells' that kill cells infected by virus. However, during prolonged infection or in the elderly the number of different killer T cells that recognise the virus is greatly reduced. This reduction in the diversity of the immune response allows the virus to avoid immune recognition, and leads to more severe infection. We aim to understand how diversity is generated in the immune response, and how it becomes narrowed with age or prolonged infection. This information can be used to design vaccines for persistent infections such as HIV, and to improve immune control of infection in the elderly.
    Read more Read less
    More information
    Funded Activity

    Linkage Projects - Grant ID: LP0455698

    Funder
    Australian Research Council
    Funding Amount
    $100,668.00
    Summary
    Novel lipid-based adjuvants for induction of mucosal immunity. The project will determine if needle-free oral and transcutaneous immunisation using LipoVax, a novel lipid-based antigen delivery system developed by the industry partner, can protect mice against the mucosal pathogens Chlamydia and Helicobacter. We expect to show that this immunisation method can induce protective mucosal immunity against two of the most common infectious organisms affecting mankind. If successful this will allow u .... Novel lipid-based adjuvants for induction of mucosal immunity. The project will determine if needle-free oral and transcutaneous immunisation using LipoVax, a novel lipid-based antigen delivery system developed by the industry partner, can protect mice against the mucosal pathogens Chlamydia and Helicobacter. We expect to show that this immunisation method can induce protective mucosal immunity against two of the most common infectious organisms affecting mankind. If successful this will allow us to develop LipoVax as a new platform technology that can be applied to the development of human vaccines, veterinary vaccines, vaccines for companion animals and vaccines to target infections in feral animals and native wildlife population populations.
    Read more Read less
    More information
    Funded Activity

    Linkage Projects - Grant ID: LP0219675

    Funder
    Australian Research Council
    Funding Amount
    $298,748.00
    Summary
    A New Recombinant Subunit Vaccine against Equine Herpesviruses 1 and 4. Equine herpesviruses 1 and 4 (EHV-1 and EHV-4) cause respiratory disease, abortion and myeloencephalitis in horse populations worldwide. Despite extensive use of whole virus vaccines, these two viruses continue to circulate among Australian horses and are a continuing threat to brading, and to racing performance. The current vaccines are expensive and are marked in Australia by an overseas company. The project will assess th .... A New Recombinant Subunit Vaccine against Equine Herpesviruses 1 and 4. Equine herpesviruses 1 and 4 (EHV-1 and EHV-4) cause respiratory disease, abortion and myeloencephalitis in horse populations worldwide. Despite extensive use of whole virus vaccines, these two viruses continue to circulate among Australian horses and are a continuing threat to brading, and to racing performance. The current vaccines are expensive and are marked in Australia by an overseas company. The project will assess the ability of a new subunit vaccine produced by recombinant DNA technology to 1) provide horses with high levels of protective immune responses and 2) to prevent or limit EHV-1 and EHV-4 infection following experimental challenge.
    Read more Read less
    More information
    Funded Activity

    Linkage Projects - Grant ID: LP0775052

    Funder
    Australian Research Council
    Funding Amount
    $75,354.00
    Summary
    Equine rhinitis A virus; molecular pathogenesis and methods for control. The horse industry in Australia is primarily based in rural locations and is a major contributor to the national economy both in terms of direct economic contribution to gross domestic product and as a major employer of people in regional Australia. The research proposed in this project will improve our understanding of the pathogenesis of a virus that causes respiratory disease in horses that is related to the virus that c .... Equine rhinitis A virus; molecular pathogenesis and methods for control. The horse industry in Australia is primarily based in rural locations and is a major contributor to the national economy both in terms of direct economic contribution to gross domestic product and as a major employer of people in regional Australia. The research proposed in this project will improve our understanding of the pathogenesis of a virus that causes respiratory disease in horses that is related to the virus that causes foot and mouth disease in ruminants and swine. The technology developed during this project would have a global market.
    Read more Read less
    More information

    Showing 1-10 of 10 Funded Activites

    Advanced Search

    Advanced search on the Researcher index.

    Advanced search on the Funded Activity index.

    Advanced search on the Organisation index.

    National Collaborative Research Infrastructure Strategy

    The Australian Research Data Commons is enabled by NCRIS.

    ARDC CONNECT NEWSLETTER

    Subscribe to the ARDC Connect Newsletter to keep up-to-date with the latest digital research news, events, resources, career opportunities and more.

    Subscribe

    Quick Links

    • Home
    • About Research Link Australia
    • Product Roadmap
    • Documentation
    • Disclaimer
    • Contact ARDC

    We acknowledge and celebrate the First Australians on whose traditional lands we live and work, and we pay our respects to Elders past, present and emerging.

    Copyright © ARDC. ACN 633 798 857 Terms and Conditions Privacy Policy Accessibility Statement
    Top
    Quick Feedback